In addition, the ratio of Tim-3 to Tim-1 in different T-cell subsets was increased in T1D in the remission phase compared with T1D, indicating an imbalance between pro- and anti-inflammatory properties in T1D patients. This evidence concerns the gene HAVCR2 and type 1 diabetes mellitus.